Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
The purpose of this trial is to test whether treatment with tralokinumab (administered subcutaneous injections \[SC\]) in combination with topical corticosteroids (TCS) is safe and effective to treat moderate-to-severe atopic dermatitis (AD) in children and infants. This will be judged by a range of assessments that rate the severity and extent of atopic dermatitis and its symptoms, as well as general health status and quality of life. The trial will last for up to 4 years. There will be visits
Sponsor: LEO Pharma
Check if you qualify for this atopic dermatitis clinical trial in Palo Alto, CA
If you're searching for atopic dermatitis treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.